September 15th, 2020 — Longtime CEO Roundtable members Steve Perrin and Walter Ogier are pleased to announce a major funding milestone for Anelixis, the company spun out of ALS Therapy Development Institute, helmed by Perrin.
This is the largest-ever new money financing of a biopharma/biotech merger between a technology-rich private company (Anelixis) with a publicly traded shell company (Novus).
